ArslonHeart-CAD Early Screening for Ischemic Heart Disease

ArslonHeart-CAD is an AI-based medical software solution being developed for the early screening of ischemic heart disease. Using standard 12-lead ECG data, the solution analyzes a routine 10-second ECG with deep learning and Graph Neural Network (GNN) technologies to assess coronary artery stenosis and myocardial ischemia-related information.

Unlike conventional diagnostic procedures that may involve radiation, contrast agents, or invasive procedures, ArslonHeart-CAD is designed to provide a simple and non-invasive approach based on an ECG that is already widely used in routine healthcare and health screening.

The solution is intended to support the identification of patients who may require further cardiovascular evaluation and to assist clinical decision-making. Arslon is currently conducting clinical and technical validation with medical and research institutions and is preparing for regulatory approval and commercialization.